Xcout Intel
Karius
Karius, Inc. is a biotechnology research company headquartered in Redwood City, California, United States. Founded in 2014 based on Stanford University intellectual property, it specializes in advanced infectious disease diagnostics.
Subscribe to see Karius’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Karius at a glance
Karius is a diagnostics company headquartered in United States. Xcout tracks 8 named people at Karius, including Alec Ford (Chief Executive Officer). Xcout recorded 24 job postings from Karius in the last 90 days, naming tools such as Salesforce.
Karius leadership
- Alec FordChief Executive Officer
- Bill QuirkChief Financial Officer
- Bradley PerkinsChief Medical Officer
- Mark AguillardChief Commercial Officer
- Sivan BercoviciChief Technology and Business Officer
- Stacy AuroraChief People Officer
2 more named people on record for Karius, with roles, board committees and tenure — see the full roster →
Hiring at Karius
Xcout recorded 24 job postings from Karius in the last 90 days, from a hiring record Xcout has kept since October 2026.
Tools named in Karius's job postings
The weekly hiring trend, the roles and locations behind it — see Karius's hiring signals →
Tech stack
Karius competitors
A few of Karius's closest competitors — see the full list of competitors and alternatives →
Day Zero Diagnostics is a biotechnology company developing rapid, sequencing-based diagnostic tests to identify bloodstream infections and predict antimicrobial resistance. Its products are intended for hospitals and clinicians managing seriously ill patients who need faster pathogen identification and antibiotic-selection information.
Day Zero Diagnostics, Inc. is a Boston-based company founded in 2016 that is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to address antibiotic resistance.
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Delve Bio is a privately held biotechnology company that serves as the exclusive licensee and provider of the University of California San Francisco's metagenomic sequencing (mNGS) test.
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casφ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editing in in vivo settings.
CosmosID is a microbial genomics and bioinformatics company providing NGS services, metagenomics solutions, and rapid characterization of microorganisms. Serving the microbiome and infectious disease markets, it functions as a leading microbiome contract research organization in North America.
Get Karius's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Karius? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Karius in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access